Cementless Total Knee Arthroplasty Market Overview

Cementless total knee arthroplasty (TKA) is an advanced surgical approach that eliminates the need for bone cement in joint replacement. Instead, the implant relies on bone growth for long-term fixation, providing more natural integration and stability. As the demand for long-lasting and biologically friendly orthopedic solutions grows, cementless TKA has gained popularity among surgeons and patients. The increasing prevalence of arthritis, rising geriatric population, and advances in implant technology have significantly contributed to market expansion. This market plays a critical role in modern orthopedic care, supporting mobility and quality of life.

Cementless Total Knee Arthroplasty Market Size and Share

The cementless total knee arthroplasty market trend was valued at USD 5.73 billion in 2024. Driven by increasing patient preference for minimally invasive and long-lasting knee implants, the market is forecasted to experience a compound annual growth rate (CAGR) of 14.6% during 2025–2034. By the end of 2034, it is projected to reach a market value of USD 19.54 billion. North America currently holds a dominant share due to technological advancements and favorable reimbursement policies, while emerging economies in the Asia Pacific are rapidly catching up.

Cementless Total Knee Arthroplasty Market Trends

Surge in Demand for Minimally Invasive and Cementless Procedures
Cementless total knee arthroplasty is gaining traction due to its minimally invasive nature and biological fixation advantages. Patients experience reduced post-operative complications and improved mobility, which is influencing both patient and surgeon preferences globally. This trend is fueled by the rising awareness of advanced orthopedic solutions and increased accessibility in developing countries.

Technological Advancements in Implant Materials and Design
Advancements in 3D printing, porous coating techniques, and biologically active surface materials are enhancing implant longevity and integration. These innovations have led to the development of lighter, more durable, and patient-specific components, which improve clinical outcomes and promote natural bone growth around the implant.

Geriatric Population Driving Market Demand
With people living longer, the global elderly population is experiencing a rise in degenerative joint diseases such as osteoarthritis. This demographic is more inclined toward surgical interventions like cementless TKA for sustained relief and better mobility. This shift is substantially increasing procedure volumes across orthopedic centers and hospitals worldwide.

Shift Towards Value-Based Healthcare and Reimbursement Reforms
Favorable reimbursement structures in regions like North America and Europe are encouraging hospitals to adopt cost-effective yet high-quality implants. With insurers focusing on long-term outcomes and patient satisfaction, cementless TKAs are being widely adopted due to their reduced revision rates and enhanced durability, aligning with value-based care objectives.

Cementless Total Knee Arthroplasty Market Analysis

Rising Incidence of Arthritis and Joint Disorders
The increasing global burden of arthritis, especially osteoarthritis and rheumatoid arthritis, is a major factor fueling demand for cementless TKA. The World Health Organization estimates over 500 million people globally suffer from osteoarthritis, many of whom require surgical interventions for pain relief and improved function.

Growing Preference Among Younger Patients
Younger patients requiring knee arthroplasty prefer cementless options due to their potential for longevity and reduced need for revision surgery. As sports injuries and active lifestyles rise among younger demographics, demand for durable and flexible joint implants continues to grow.

Advancements in Surgical Techniques and Navigation
Technologies like robotic-assisted surgery, computer navigation, and intraoperative imaging are improving precision during knee arthroplasty procedures. These developments enhance the performance and reliability of cementless implants, thus boosting their market appeal.

Economic and Healthcare Infrastructure Improvements
Developing regions such as Asia Pacific and Latin America are investing heavily in healthcare infrastructure, expanding access to advanced orthopedic treatments. This, coupled with medical tourism growth, is accelerating the adoption of cementless TKA in emerging markets.

Cementless Total Knee Arthroplasty Market – Don’t Miss Out! Discover where the industry is headed and how to stay competitive. Download your complimentary report!

Cementless Total Knee Arthroplasty Scope of the Report

The report provides a comprehensive analysis of historical and forecast trends in the cementless total knee arthroplasty market from 2018 to 2034. It assesses key industry drivers and constraints, evaluates segment-wise performance, and explores growth opportunities across regions and end users. Data-driven insights and strategic developments are examined to help stakeholders understand market dynamics.

Historical and Forecast Trends, Industry Drivers and Constraints

The market has experienced consistent growth since 2018 due to technological innovation, patient awareness, and demographic shifts. Constraints include the high cost of implants, limited accessibility in low-income regions, and surgical complications in some cases. However, robust product pipelines, R&D investments, and policy support are expected to mitigate these barriers over the forecast period.

Historical and Forecast Market Analysis by Segment

Breakup by Components

Tibial Component
The tibial component forms the base of the implant, where weight-bearing functions are critical. Demand for cementless tibial components is increasing as innovations offer better bone integration and reduced micromotion, especially in active patients.

Femoral Component
The femoral component, which articulates with the tibia, has seen advancements in anatomical designs that provide better fit and reduce stress on surrounding tissues. Cementless femoral components are increasingly preferred for their durable fixation and adaptability to different bone densities.

Breakup by End User

Hospitals
Hospitals account for the largest share of the market, given their comprehensive facilities, access to surgical technologies, and presence of specialized orthopedic surgeons. They are also primary centers for insurance-covered procedures.

Orthopedic Centers
These specialized centers are growing rapidly due to focused expertise, shorter wait times, and better patient satisfaction rates. Their adoption of cementless TKA is driven by quality-of-care outcomes and patient-centric approaches.

Other End-Users
Includes ambulatory surgical centers and academic research institutions. Though smaller in share, these facilities contribute to market growth through clinical trials, education, and niche procedures.

Cementless Total Knee Arthroplasty Regional Insights

North America and Europe
North America dominates the market due to high arthritis prevalence, advanced healthcare systems, and robust reimbursement policies. The U.S. sees widespread adoption of cementless techniques, backed by technological integration in surgical procedures. Europe follows closely, with Germany, France, and the U.K. promoting orthopedic care reforms and aging population management.

Asia Pacific, Latin America, Middle East, and Africa
Asia Pacific is emerging as a key growth market, driven by healthcare modernization and increasing joint disease prevalence. Countries like India and China are investing in orthopedic research and infrastructure. Latin America and the Middle East & Africa show gradual uptake, with Brazil, South Africa, and GCC countries expanding orthopedic care and attracting medical tourism.

Cementless Total Knee Arthroplasty Market Growth

The market is poised for strong growth due to a combination of medical, demographic, and technological factors. Rising awareness about the benefits of cementless implants, coupled with growing acceptance among surgeons, is creating ample opportunities. Technological convergence — such as AI in surgery and regenerative implant coatings — will further unlock potential. Emerging markets are expected to contribute significantly as healthcare access improves and government spending increases.

Recent Developments & Challenges

• Zimmer Biomet Launches Persona IQ Smart Knee
  Zimmer Biomet introduced an innovative smart cementless knee implant with real-time remote monitoring via embedded sensors, enhancing post-operative care and analytics.

• Stryker Acquires OrthoSensor
  Stryker’s acquisition strengthens its data-driven orthopedic offerings, supporting cementless solutions with motion tracking and joint performance analytics.

• FDA Approves New Cementless Knee Systems
  Regulatory bodies like the FDA have approved new-generation cementless knees with enhanced biocompatibility, opening avenues for global market entry and patient adoption.

• Challenges in Revision Surgeries
  Though cementless TKAs have lower revision rates, they may pose complexities if revision is needed. This challenge requires ongoing surgeon training and product optimization.

Cementless Total Knee Arthroplasty Key Players

Stryker
Stryker is a leader in orthopedic innovation, offering a range of cementless knee systems like the Triathlon Tritanium. With strong R&D investment and surgeon-focused technology, Stryker continues to shape the future of knee arthroplasty, focusing on precision implants and digital surgery solutions.

Smith & Nephew
Smith & Nephew’s JOURNEY II system includes cementless options with a focus on high flexion and natural movement. The company is known for its commitment to research and patient-specific solutions, with a global footprint supporting wide accessibility and surgeon training programs.

Zimmer Biomet
Zimmer Biomet’s cementless knee portfolio includes the Persona and NexGen series, emphasizing fit and fixation. With smart knee technologies and advanced material science, the company is leading innovation and enhancing surgical precision and patient satisfaction globally.

Johnson & Johnson (DePuy Synthes)
DePuy Synthes delivers high-quality, biologically integrated implants that support natural bone growth and reduce the risk of loosening. The ATTUNE system is a notable product in the cementless knee segment, designed to optimize movement and improve long-term performance.

Other Notable Companies
B. Braun SE, Olympus Corporation (GROUP FH ORTHO), DJO, LLC (Enovis), X.NOV (C2F IMPLANTS), and Corin Group plc are also key players contributing to market innovation and expanding global access.

FAQs

Q1. What is cementless total knee arthroplasty?
Cementless TKA is a surgical procedure where knee implants are fixed without bone cement, relying on bone growth for stability and long-term fixation.

Q2. What is driving the growth of the cementless TKA market?
Key drivers include rising arthritis cases, aging population, demand for long-lasting implants, and technological innovations in orthopedic surgery.

Q3. Which regions are leading the cementless TKA market?
North America currently leads the market, followed by Europe. Asia Pacific is witnessing rapid growth due to improved healthcare infrastructure.

Q4. Who are the key players in the cementless TKA market?
Major companies include Stryker, Smith & Nephew, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), along with B. Braun, Olympus, DJO (Enovis), X.NOV, and Corin Group.

Q5. What is the market outlook for 2034?
The market is projected to reach USD 19.54 billion by 2034, growing at a CAGR of 14.6%, driven by innovation, patient awareness, and emerging market expansion.

View More Studies

Medical Spa Market

Assisted Reproductive Technology Market

Cannabis Market

Advanced Wound Care Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com